Grant & Eisenhofer P.A.

Grant & Eisenhofer is one of the most successful plaintiff advocacy firms in the country. With extensive trial skills, G&E has successfully litigated numerous individual claims in state, federal and appellate courts. Our experienced attorneys are investigating vision loss claims due to Elmiron. Contact us by submitting the form or by calling us at (866) 575-7435 for a confidential evaluation of your potential claim.

Elmiron and Macular Degeneration

The link between Elmiron and vision damage has come to the forefront of recent news—as well as the courtroom. Many patients experiencing vision loss symptoms are looking for answers to questions such as: does Elmiron cause macular degeneration? Our law firm is investigating vision loss claims nationwide due to Elmiron. Learn more about Elmiron, vision …. Read More

Comments Off on Elmiron and Macular Degeneration

Multi-District Litigation Status Granted in Elmiron Litigation

In the latest news in the Elmiron litigation, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has approved all Elmiron lawsuits to be consolidated in the District of New Jersey before Brian R. Martinotti. This tactic, called a multi-district litigation, or MDL, consolidates cases that allege similar claims to expedite pretrial proceedings and eliminate duplicative …. Read More

Comments Off on Multi-District Litigation Status Granted in Elmiron Litigation

Case Report Suggests Elmiron May Effect Vision Years Post-Treatment  

As patients that took Elmiron continue to file lawsuits concerning its vision-loss side-effects, a new case report indicates some alarming findings. In the report, published in Retinal Cases & Brief Reports, doctors from Emory University School of Medicine describe a woman who experienced vision problems three years after stopping Elmiron. The 44-year old developed Elmiron-induced …. Read More

Comments Off on Case Report Suggests Elmiron May Effect Vision Years Post-Treatment  

Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

As litigation against Janssen Pharmaceuticals, manufacturer of bladder pain drug Elmiron, mounts, the FDA has approved a change in the drug’s labeling in the U.S. The label of the drug’s “Warnings” section previously did not list any risks concerning visual impairment; however, labeling must now contain “Retinal Pigmentary Changes.” These changes may manifest as pigmentary …. Read More

Comments Off on Elmiron Manufacturer Updates U.S. Drug Label to Warn of Potential Eye Damage

Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use

In one of the first cases concerning eye damage related to drug Elmiron, the complaint filed in New Jersey Superior Court alleges failure to warn of the drug’s side effects. Elmiron is a prescription drug widely used to treat a bladder pain condition known as interstitial cystitis. Concerns relating to potentially permanent vision loss and …. Read More

Comments Off on Lawsuit Alleges Vision Injury, Pigmentary Maculopathy Due to Elmiron Use